Protagonist Therapeutics Inc - PTGX - stock price prediction, stock price target, analyst ratings from 13 analysts

Protagonist Therapeutics Inc has a share price target of US$ 133, revenue growth forecast of 1051.3%, and profit growth estimate of 314.6% for FY26, based on top 13 analyst calls.